Effect of Pre-emptive Intravenous Immunoglobulin (IVIG) on the Incidence of Septic Episodes in Pediatric Burn Patients
Clinical trial NCT05134792 · COMPLETED
Trial details
- NCT number
- NCT05134792
- Sponsor
- Cairo University
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-10
- Primary completion
- 2022-07-16
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.